Cardlytics

$119.33
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$3.79 (-3.08%) Today

$0.00 (0.00%) As of 10:00 PM UTC after-hours

Why Robinhood?

You can buy or sell Cardlytics and other stocks, options, and ETFs commission-free!

About CDLX

Cardlytics, Inc. engages in the development of marketing solutions through its purchase intelligence platform. It operates through the Cardlytics Direct and Other Platform Solutions segments. The Cardlytics Direct segment represents its proprietary native bank advertising channel. The Other Platform Solutions segment includes solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded by Scott D. Grimes, Lynne M. Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA. The listed name for CDLX is Cardlytics, Inc. Common Stock.

CEO

Lynne Marie Laube

Employees

432

Headquarters

Atlanta, Georgia

Founded

2008

Market Cap

3.28B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

407.76K

High Today

$124.12

Low Today

$118.30

Open Price

$123.11

Volume

305.96K

52 Week High

$125.50

52 Week Low

$27.33

Collections

Technology

Advertising and Marketing

CDLX News

MarketWatchNov 26

How the pandemic presented a stock-market opportunity to Sen. David Perdue of Georgia

WASHINGTON (AP) — As the ravages of the novel coronavirus forced millions of people out of work, shuttered businesses and shrank the value of retirement account

Analyst Ratings

29%

of 7 ratings

Buy

29%

Hold

71%

Sell

CDLX Earnings

-$0.47

-$0.25

-$0.04

$0.18

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 2, After Hours